Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)

Zagiel, B; Melnyk, P; Cotelle, P

Cotelle, P (通讯作者),Univ Lille, CHU Lille, INSERM, Lille Neurosci & Cognit Res Ctr,UMR S 1172, F-59000 Lille, France.

EXPERT OPINION ON THERAPEUTIC PATENTS, 2022; 32 (8): 899

Abstract

Introduction The Hippo pathway represents a new opportunity for the treatment of cancer. Overexpression of Yes-associated protein (YAP) or transcripti......

Full Text Link